Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma.
Cancers (Basel). 2020 Jun 30;12(7):1744. doi: 10.3390/cancers12071744.
Cancers (Basel). 2020.
PMID: 32629964
Free PMC article.
The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.
Zhou L, Lyons-Rimmer J, Ammoun S, Müller J, Lasonder E, Sharma V, Ercolano E, Hilton D, Taiwo I, Barczyk M, Hanemann CO.
Zhou L, et al. Among authors: lyons rimmer j.
Oncogene. 2016 Jun 30;35(26):3443-53. doi: 10.1038/onc.2015.404. Epub 2015 Nov 9.
Oncogene. 2016.
PMID: 26549023
Free PMC article.
Item in Clipboard
Cellular prion protein (PrPC) in the development of Merlin-deficient tumours.
Provenzano L, Ryan Y, Hilton DA, Lyons-Rimmer J, Dave F, Maze EA, Adams CL, Rigby-Jones R, Ammoun S, Hanemann CO.
Provenzano L, et al. Among authors: lyons rimmer j.
Oncogene. 2017 Nov 2;36(44):6132-6142. doi: 10.1038/onc.2017.200. Epub 2017 Jul 10.
Oncogene. 2017.
PMID: 28692055
Item in Clipboard
Cite
Cite